RenalSense Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$14M
- Investors
-
5
RenalSense General Information
Description
Developer of a critical care monitoring system designed for real-time renal diagnostics, especially for patients at risk of acute kidney injury. The company's monitoring system continuously measures urine flow, automatically transmitting real-time data and notifications of fluctuations, on a clock basis, facilitating doctors with early detection of changes in renal function and acute kidney injury risk, enabling the medical system to access a suitable technology for early detection of changes and prevention of disease progression.
Contact Information
Website
www.renalsense.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Other Healthcare Technology Systems
Primary Office
- Hamarpe 3, Har Hotzvim
- POB 45397
- Jerusalem 9145101
- Israel
+972 00-000-0000
RenalSense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC (Series A) | 22-Nov-2021 | $14M | 0000 | Completed | Generating Revenue | |
| 4. Grant | 01-Nov-2019 | 000.00 | 000 | Completed | Generating Revenue | |
| 3. Grant | 30-May-2019 | 00000 | 000 | Completed | Generating Revenue | |
| 2. Angel (individual) | 01-Jan-2018 | $3.5M | $8M | Completed | Generating Revenue | |
| 1. Later Stage VC (Series A) | 31-Dec-2015 | $4.5M | $4.5M | Completed | Generating Revenue |
RenalSense Patents
RenalSense Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3755975-A1 | Sensor unit | Pending | 19-Feb-2018 | 000000000 | |
| US-11333534-B2 | Sensor unit | Active | 19-Feb-2018 | 000000000 | 0 |
| US-20200393273-A1 | Sensor unit | Active | 19-Feb-2018 | 000000000 | |
| US-20220236087-A1 | Sensor unit | Pending | 19-Feb-2018 | 000000000 | 0 |
| EP-3755975-A4 | Sensor unit | Pending | 19-Feb-2018 | G01D11/30 | 0 |
RenalSense Executive Team (6)
RenalSense Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Avi Kleiman | RenalSense | Co-Founder, Chief Executive Officer & Chairman | 000 0000 |
| Cuong Do | Self | Board Member | 000 0000 |
| Milton Yisrael | RenalSense | Board Member | 000 0000 |
| Yishai Klein | Self | Board Member | 000 0000 |
RenalSense Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
RenalSense Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BlueRed Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Thylacine Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Horizon 2020 SME Instrument | Government | 000 0000 | 000000 0 | ||
| Israel Innovation Authority | Government | 000 0000 | 000000 0 | ||
| Ministry of Economy and Industry | Government | 000 0000 | 000000 0 |